Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$9.31 -0.08 (-0.85%)
At close: Nov 11, 2026 · 4:00 PM EST

Arcturus Therapeutics Holdings (ARCT) Return on Assets [ROA] (2019 - 2026)

Updated

Arcturus Therapeutics Holdings' Return on Assets [ROA] came in at -40.55% for Q2 2026, down 21.78 percentage points from -18.77% a year earlier and down 9.33 percentage points from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) Return on Assets [ROA] (2019 - 2026) Analysis & Trends

For FY2025, Arcturus Therapeutics Holdings' Return on Assets [ROA] was -21.39%, down 0.46 percentage points from FY2024.

  • Return on Assets [ROA] has declined in each of the last three years, though with a five-year change of +4.22 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Assets [ROA] was -20.93% in FY2024 (-14.17 pp), -6.76% in FY2023 (-8.97 pp), 2.22% in FY2022 (+49.08 pp) and -46.86% in FY2021 (-21.25 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Assets [ROA] since Q3 2022.
  • Year-over-year, Return on Assets [ROA] has declined for five consecutive quarters, with an average year-over-year change of -11.37 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in Q1 2023 (a gain of 77.91 percentage points), and the weakest in Q1 2024 (a drop of 49.74 percentage points).
  • Business Quant data shows ARCT's Return on Assets [ROA] at -31.22% (Q1 2026), -23.77% (Q4 2025) and -22.55% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Arcturus Therapeutics Holdings 267.25 Mn -551.34 Mn - -39.69%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -39.69%
Jun 30, 2026 -39.72%
Mar 31, 2026 -30.46%
Dec 31, 2025 -23.77%
Sep 30, 2025 -22.55%
Jun 30, 2025 -18.77%
Mar 31, 2025 -20.18%
Dec 31, 2024 -22.65%
Sep 30, 2024 -16.50%
Jun 30, 2024 -17.82%
Mar 31, 2024 -25.30%
Dec 31, 2023 -6.70%
Sep 30, 2023 22.36%
Jun 30, 2023 17.81%
Mar 31, 2023 24.16%
Dec 31, 2022 2.51%
Sep 30, 2022 -46.51%
Jun 30, 2022 -48.74%
Mar 31, 2022 -54.03%
Dec 31, 2021 -49.24%
API Access

Arcturus Therapeutics Holdings Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ARCT&period=max&api_key=YOUR_API_KEY